TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 60 filers reported holding TAYSHA GENE THERAPIES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,021,366 | +1180.0% | 323,217 | +223.1% | 0.00% | – |
Q1 2023 | $79,795 | -79.6% | 100,044 | -42.3% | 0.00% | – |
Q4 2022 | $391,938 | +1206.5% | 173,424 | +1011.7% | 0.00% | – |
Q3 2022 | $30,000 | -62.0% | 15,600 | -26.3% | 0.00% | – |
Q2 2022 | $79,000 | – | 21,163 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO | 1,147,040 | $13,363,000 | 6.07% |
Sands Capital Ventures, LLC | 724,873 | $8,445,000 | 1.25% |
Quantum Private Wealth, LLC | 145,718 | $1,697,000 | 0.64% |
Nantahala Capital Management | 1,456,147 | $16,964,000 | 0.60% |
Artal Group S.A. | 1,040,882 | $12,126,000 | 0.33% |
Alphabet Inc. | 640,882 | $7,466,000 | 0.18% |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 500,000 | $5,825,000 | 0.17% |
TimesSquare Capital Management, LLC | 659,100 | $7,679,000 | 0.07% |
GSA CAPITAL PARTNERS LLP | 40,885 | $476,000 | 0.06% |
Virtus ETF Advisers LLC | 11,519 | $134,000 | 0.05% |